Pluristem's Phase I/II Muscle Injury Trial Results to be Announced on January 21, 2014
January 06, 2014 at 05:45 AM EST
Pluristem Therapeutics (Nasdaq: PSTI ) today announced that the results of the company's Phase I/II clinical trial testing the safety and efficacy of PLacental Expanded (PLX-PAD) cells for the treatment of muscle injury will be presented on January 21, 2014. See full press release (c) 2014
